Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Graft-versus-host disease	4/42	1.2961519981889268e-07	1.1665367983700341e-05	140.87719298245614	-275.439099811649	HLA-A;HLA-DRB1;IL6;TNF
KEGG_2021_Human	Allograft rejection	3/38	1.1267399953362688e-05	0.0004928827174312841	98.36326530612244	-155.5765022451814	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Type I diabetes mellitus	3/43	1.6429423914376138e-05	0.0004928827174312841	86.01428571428572	-141.158089869663	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	4/219	9.708345438267137e-05	0.0012727616683559676	24.350387596899225	-67.12577033726024	HLA-A;HLA-DRB1;IL6;TNF
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0012727616683559676	55.34101382488479	-100.98537671170521	HLA-DRB1;IL6;TNF
KEGG_2021_Human	Antigen processing and presentation	3/78	9.899257420546415e-05	0.0012727616683559676	45.674285714285716	-86.62026988813746	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Epstein-Barr virus infection	4/202	7.083103438365334e-05	0.0012727616683559676	26.4983164983165	-72.60755777125968	HLA-A;HLA-DRB1;IL6;TNF
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0018811021700858546	37.99047619047619	-74.4091590745228	HLA-DRB1;IL6;TNF
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.0020131554786600543	35.589285714285715	-70.42440314178907	HLA-DRB1;IL6;TNF
KEGG_2021_Human	TNF signaling pathway	3/112	0.00029005838446074546	0.002610525460146709	31.293577981651374	-63.06696788213405	IL6;TNF;TRAF1
KEGG_2021_Human	Asthma	2/31	0.0006292457268839483	0.005148374129050486	69.30172413793103	-73.992829918215	HLA-DRB1;TNF
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.0067325701145139185	57.378571428571426	-64.24352876962546	IL6;TNF
KEGG_2021_Human	Influenza A	3/172	0.001019644326496313	0.0070590761065129366	20.0312764158918	-42.078889135072146	HLA-DRB1;IL6;TNF
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.007479183459392195	19.106537530266344	-40.222430877266724	HLA-DRB1;IL6;TNF
KEGG_2021_Human	Intestinal immune network for IgA production	2/48	0.0015093757711636376	0.008719021256839514	43.59782608695652	-51.89779709972968	HLA-DRB1;IL6
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.008719021256839514	41.770833333333336	-50.1560330081587	IL6;TNF
KEGG_2021_Human	Viral carcinogenesis	3/203	0.0016469262374030193	0.008719021256839514	16.86	-35.61063787888018	HLA-A;TRAF1;YWHAH
KEGG_2021_Human	Autoimmune thyroid disease	2/53	0.0018378173017361363	0.009189086508680682	39.299019607843135	-47.75438384041307	HLA-A;HLA-DRB1
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.009526768406762559	15.146718146718147	-31.989452913184095	HLA-A;IL6;TNF
KEGG_2021_Human	Legionellosis	2/57	0.0021229405609363423	0.009526768406762559	36.42272727272727	-44.890022889750604	IL6;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	4/498	0.002222912628244597	0.009526768406762559	10.22132253711201	-27.191293900864785	HLA-A;HLA-DRB1;IL6;TNF
KEGG_2021_Human	Viral myocarditis	2/60	0.0023497251222600107	0.009612511863790953	34.525862068965516	-42.95708800176444	HLA-A;HLA-DRB1
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.014403535293649884	26.643333333333334	-34.49723066158141	HLA-DRB1;TNF
KEGG_2021_Human	Pertussis	2/76	0.0037436519554145367	0.014403535293649884	27.006756756756758	-34.90410589940028	IL6;TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.01876446128379837	22.670454545454547	-29.92662218019896	IL6;TNF
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.018835634804089854	19.92	-26.61700675496218	IL6;TNF
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.018835634804089854	19.92	-26.61700675496218	IL6;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.018835634804089854	20.331632653061224	-27.120602948412195	IL6;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.018835634804089854	19.524509803921568	-26.130280011490946	IL6;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.018835634804089854	19.524509803921568	-26.130280011490946	IL6;TNF
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.018835634804089854	21.67391304347826	-28.742216935482162	IL6;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	2/104	0.006906399428166279	0.018835634804089854	19.524509803921568	-26.130280011490946	TNF;TRAF1
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.018835634804089854	20.331632653061224	-27.120602948412195	IL6;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.019107967411947903	18.95952380952381	-25.42995427691617	HLA-DRB1;IL6
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.019107967411947903	18.778301886792452	-25.204052222837845	IL6;TNF
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.019932640639279034	18.086363636363636	-24.33571316400054	HLA-DRB1;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.024716734827646785	15.886	-21.510038502238015	FOSL2;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.0255446992742488	15.385658914728682	-20.853034219946885	HLA-A;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.026369072862601584	14.915413533834586	-20.230385574789178	HLA-DRB1;TNF
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.026445144997612614	14.690740740740742	-19.931093924152265	IL6;TNF
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.027633376723174476	14.157142857142857	-19.21549786230027	TNF;TRAF1
KEGG_2021_Human	Cell adhesion molecules	2/148	0.0136245920729854	0.02919555444211157	13.565068493150685	-18.413416454449223	HLA-A;HLA-DRB1
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.029831025909945307	12.847402597402597	-17.429441058365175	HLA-A;IL6
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.029831025909945307	12.762903225806452	-17.312716751580805	TNF;YWHAH
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.029831025909945307	12.933006535947712	-17.54750234216727	IL6;TNF
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.029831025909945307	13.196666666666667	-17.909946150058477	HLA-A;HLA-DRB1
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.030989068795074126	12.35625	-16.748364182562245	IL6;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	2/181	0.019962543247368986	0.03742976858881685	11.018156424581006	-14.859767863470836	IL6;TNF
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.040546025918544275	10.365789473684211	-13.920708621090329	IL6;TRAF1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.040546025918544275	10.31020942408377	-13.840129933766221	HLA-A;IL6
KEGG_2021_Human	Pathogenic Escherichia coli infection	2/197	0.0234094024256627	0.041310710162934174	10.093589743589744	-13.525208778126117	IL6;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	2/212	0.026851997557997137	0.04647461115807197	9.354761904761904	-12.440530405951861	HLA-A;TNF
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.0468074709273746	9.219483568075118	-12.240131856521	IL6;TNF
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.05291274524810716	8.519565217391305	-11.194266119915625	IL6;TNF
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.05919124115300223	7.915991902834008	-10.280113155611538	IL6;TNF
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.06880434088010988	7.192804428044281	-9.169844698845731	IL6;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.07781162545580086	6.6339590443686	-8.300944532041967	IL6;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.08617913501580785	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.0924472622098113	5.880699088145897	-7.115618067766183	HLA-A;TNF
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.102428545627044	5.480113636363637	-6.479364551821025	IL6;YWHAH
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.10839966698887925	5.2459128065395095	-6.1057863985118	IL6;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.10937787913273617	14.347670250896057	-8.574814690072902	IL6
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.1154735948337934	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.1154735948337934	12.880837359098228	-7.74542097629872	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.1154735948337934	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.14395933017224663	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.14395933017224663	4.014270613107822	-4.131104230952899	IL6;TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.14395933017224663	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.14395933017224663	9.739926739926739	-5.8737398650795125	HLA-DRB1
KEGG_2021_Human	Staphylococcus aureus infection	1/95	0.11162978125448282	0.14395933017224663	9.425531914893616	-5.678293992521663	HLA-DRB1
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.14395933017224663	9.739926739926739	-5.8737398650795125	TRAF1
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.1520002042539345	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.15669325576506032	8.189300411522634	-4.893732148578802	IL6
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.16559263662011295	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.16559263662011295	3.5628544423440456	-3.410136075895621	IL6;TRAF1
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.16981214112056645	7.177055103884372	-4.231046804704064	YWHAH
KEGG_2021_Human	Oocyte meiosis	1/129	0.1487694756391342	0.17388640009768933	6.892361111111111	-4.041189892105298	YWHAH
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.17412691485322052	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.17935166684945533	6.384863123993559	-3.698840756963446	TNF
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.17935166684945533	6.384863123993559	-3.698840756963446	IL6
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.19464456795932356	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.19768485694816168	5.562587904360056	-3.1333425612983894	TNF
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.19768485694816168	5.422496570644719	-3.0356632226338247	YWHAH
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.19768485694816168	5.456866804692892	-3.0596637281364782	IL6
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.22332315400274583	4.657210401891253	-2.4954112144854435	PADI4
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23733181593877287	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.2753189323118414	3.547845804988662	-1.6951894904190261	TNF
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.27792358280278984	3.4603806994245243	-1.6315316807371463	HLA-A
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3134040254927865	2.9484262419416005	-1.2588658824557653	TNF
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
